Prevalence of human papillomavirus infection in women in Turin, Italy.
暂无分享,去创建一个
S. Franceschi | C. Meijer | P. Snijders | F. Merletti | A. Gillio-Tos | G. Ronco | N. Segnan | V. Ghisetti | Anna Gillio-Tos
[1] F. X. Bosch,et al. Cervical human papillomavirus infection in women attending gynaecological outpatient clinics in northern Greece , 2004, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[2] S. Franceschi,et al. Prevalence of papillomavirus infection in women in Ibadan, Nigeria: a population-based study , 2004, British Journal of Cancer.
[3] I. Catalá,et al. Cervical Human Papillomavirus Infection in the Female Population in Barcelona, Spain , 2003, Sexually transmitted diseases.
[4] D. Galloway. Papillomavirus vaccines in clinical trials. , 2003, The Lancet. Infectious diseases.
[5] N. Muñoz,et al. Prevalence of Human Papillomavirus Infection Among Women in Concordia, Argentina:: A Population-Based Study , 2003, Sexually transmitted diseases.
[6] V. Beral,et al. Human papillomavirus infection and use of oral contraceptives , 2003, British Journal of Cancer.
[7] S. Franceschi,et al. HUMAN PAPILLOMAVIRUS INFECTION AMONG WOMEN IN SOUTH AND NORTH VIETNAM , 2003 .
[8] F. X. Bosch,et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. , 2003, The New England journal of medicine.
[9] P. Coursaget,et al. Prevalence of human papillomavirus infection in women in Busan, South Korea , 2003, International journal of cancer.
[10] S. Franceschi,et al. Prevalence and determinants of HPV infection among Colombian women with normal cytology , 2002, British Journal of Cancer.
[11] V. Moreno,et al. Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study , 2002, The Lancet.
[12] P. Snijders,et al. GP5+/6+ PCR followed by Reverse Line Blot Analysis Enables Rapid and High-Throughput Identification of Human Papillomavirus Genotypes , 2002, Journal of Clinical Microbiology.
[13] A. Moscicki,et al. Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females. , 2001, JAMA.
[14] N. Muñoz,et al. Epidemiology of HPV infection among Mexican women with normal cervical cytology , 2001, International journal of cancer.
[15] J. Peto,et al. Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected: a case–control study nested within the Manchester cohort , 2000, British Journal of Cancer.
[16] S. Ciatto,et al. Prediction of high-grade cervical intraepithelial neoplasia in cytologically normal women by human papillomavirusesting , 2000, British Journal of Cancer.
[17] J. Kaczorowski,et al. Prevalence and predictors of human papillomavirus infection in women in Ontario, Canada. Survey of HPV in Ontario Women (SHOW) Group. , 2000, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[18] J. Cuzick,et al. A systematic review of the role of human papilloma virus (HPV) testing within a cervical screening programme: summary and conclusions , 2000, British Journal of Cancer.
[19] J. Walboomers,et al. Distribution of 37 mucosotropic HPV types in women with cytologically normal cervical smears: The age‐related patterns for high‐risk and low‐risk types , 2000, International journal of cancer.
[20] M. Plummer,et al. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. , 2000, Journal of the National Cancer Institute.
[21] J. Peto,et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide , 1999, The Journal of pathology.
[22] J. Ferlay,et al. Cancer Incidence in Five Continents , 1970, Union Internationale Contre Le Cancer / International Union against Cancer.
[23] M. Sherman,et al. Determinants for genital human papillomavirus (HPV) infection in 1000 randomly chosen young Danish women with normal Pap smear: are there different risk profiles for oncogenic and nononcogenic HPV types? , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[24] K. Engels,et al. The polymerase chain reaction in pathology. , 1997, Journal of clinical pathology.
[25] A. Ponti,et al. Interaction of spontaneous and organised screening for cervical cancer in Turin, Italy. , 1997, European journal of cancer.
[26] C. Meijer,et al. A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings , 1997, Journal of clinical microbiology.
[27] S. Rosso,et al. Social class and cancer survival in Turin, Italy. , 1997, Journal of epidemiology and community health.
[28] N. Muñoz,et al. Risk Factors for HPV DNA Detection in Middle‐Aged Women , 1996, Sexually transmitted diseases.
[29] J. Feldman,et al. Declining Prevalence of Cervicovaginal Human Papillomavirus Infection With Age Is Independent of Other Risk Factors , 1996, Sexually transmitted diseases.
[30] C. Meijer,et al. Group-specific differentiation between high- and low-risk human papillomavirus genotypes by general primer-mediated PCR and two cocktails of oligonucleotide probes , 1995, Journal of clinical microbiology.
[31] A. Ponti,et al. Who does Pap-test? The effect of one call program on coverage and determinants of compliance. , 1994, Epidemiologia e prevenzione.
[32] L. Brinton,et al. Determinants of Genital Human Papillomavirus Infection in Low‐Income Women in Washington, D.C , 1993, Sexually transmitted diseases.
[33] David R. Scott,et al. Determinants of Genital Human Papillomavirus Infection in Low‐Risk Women in Portland, Oregon , 1993, Sexually transmitted diseases.
[34] J. Underwood. Diagnostic Molecular Pathology. A Practical Approach , 1993 .
[35] J Cuzick,et al. A systematic review of the role of human papillomavirus testing within a cervical screening programme. , 1999, Health technology assessment.
[36] J. Higginson,et al. International Agency for Research on Cancer. , 1968, WHO chronicle.